BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 19633317)

  • 1. Haemolytic uraemic syndrome caused by factor H mutation: is single kidney transplantation under intensive plasmatherapy an option?
    Hirt-Minkowski P; Schaub S; Mayr M; Schifferli JA; Dickenmann M; Frémeaux-Bacchi V; Steiger J
    Nephrol Dial Transplant; 2009 Nov; 24(11):3548-51. PubMed ID: 19633317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A favorable 3-year outcome of kidney transplantation in atypical hemolytic uremic syndrome associated with a factor H mutation: case report.
    Albertazzi V; Bonucchi D; De Amicis S; Americo C; Ghiandai G; Cappelli G
    Transplant Proc; 2010 May; 42(4):1352-4. PubMed ID: 20534299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemolytic uremic syndrome recurrence after renal transplantation.
    Loirat C; Fremeaux-Bacchi V
    Pediatr Transplant; 2008 Sep; 12(6):619-29. PubMed ID: 18482212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome.
    Sellier-Leclerc AL; Fremeaux-Bacchi V; Dragon-Durey MA; Macher MA; Niaudet P; Guest G; Boudailliez B; Bouissou F; Deschenes G; Gie S; Tsimaratos M; Fischbach M; Morin D; Nivet H; Alberti C; Loirat C;
    J Am Soc Nephrol; 2007 Aug; 18(8):2392-400. PubMed ID: 17599974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmatherapy in atypical hemolytic uremic syndrome.
    Loirat C; Garnier A; Sellier-Leclerc AL; Kwon T
    Semin Thromb Hemost; 2010 Sep; 36(6):673-81. PubMed ID: 20865645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maintenance of kidney function following treatment with eculizumab and discontinuation of plasma exchange after a third kidney transplant for atypical hemolytic uremic syndrome associated with a CFH mutation.
    Davin JC; Gracchi V; Bouts A; Groothoff J; Strain L; Goodship T
    Am J Kidney Dis; 2010 Apr; 55(4):708-11. PubMed ID: 19854549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical haemolytic uraemic syndrome.
    Kavanagh D; Goodship TH; Richards A
    Br Med Bull; 2006; 77-78():5-22. PubMed ID: 16968692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver-kidney transplantation to cure atypical hemolytic uremic syndrome.
    Saland JM; Ruggenenti P; Remuzzi G;
    J Am Soc Nephrol; 2009 May; 20(5):940-9. PubMed ID: 19092117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic disorders in complement (regulating) genes in patients with atypical haemolytic uraemic syndrome (aHUS).
    Westra D; Volokhina E; van der Heijden E; Vos A; Huigen M; Jansen J; van Kaauwen E; van der Velden T; van de Kar N; van den Heuvel L
    Nephrol Dial Transplant; 2010 Jul; 25(7):2195-202. PubMed ID: 20106822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement factor H deficiency and posttransplantation glomerulonephritis with isolated C3 deposits.
    Boyer O; Noël LH; Balzamo E; Guest G; Biebuyck N; Charbit M; Salomon R; Frémeaux-Bacchi V; Niaudet P
    Am J Kidney Dis; 2008 Apr; 51(4):671-7. PubMed ID: 18371543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transplantation in atypical hemolytic uremic syndrome.
    Kavanagh D; Richards A; Goodship T; Jalanko H
    Semin Thromb Hemost; 2010 Sep; 36(6):653-9. PubMed ID: 20865642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The decay accelerating factor mutation I197V found in hemolytic uraemic syndrome does not impair complement regulation.
    Kavanagh D; Burgess R; Spitzer D; Richards A; Diaz-Torres ML; Goodship JA; Hourcade DE; Atkinson JP; Goodship TH
    Mol Immunol; 2007 May; 44(12):3162-7. PubMed ID: 17368771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of eculizumab and plasma exchange in successful combined liver-kidney transplantation in a case of atypical HUS associated with complement factor H mutation.
    Tran H; Chaudhuri A; Concepcion W; Grimm PC
    Pediatr Nephrol; 2014 Mar; 29(3):477-80. PubMed ID: 24221349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The interactive Factor H-atypical hemolytic uremic syndrome mutation database and website: update and integration of membrane cofactor protein and Factor I mutations with structural models.
    Saunders RE; Abarrategui-Garrido C; Frémeaux-Bacchi V; Goicoechea de Jorge E; Goodship TH; López Trascasa M; Noris M; Ponce Castro IM; Remuzzi G; Rodríguez de Córdoba S; Sánchez-Corral P; Skerka C; Zipfel PF; Perkins SJ
    Hum Mutat; 2007 Mar; 28(3):222-34. PubMed ID: 17089378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful therapeutic plasma exchange in a 3.2-kg body weight neonate with atypical hemolytic uremic syndrome.
    Jung S; Kang ES; Ki CS; Kim DW; Paik KH; Chang YS
    J Clin Apher; 2011; 26(3):162-5. PubMed ID: 21322001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional analyses indicate a pathogenic role of factor H autoantibodies in atypical haemolytic uraemic syndrome.
    Strobel S; Hoyer PF; Mache CJ; Sulyok E; Liu WS; Richter H; Oppermann M; Zipfel PF; Józsi M
    Nephrol Dial Transplant; 2010 Jan; 25(1):136-44. PubMed ID: 19666655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical hemolytic uremic syndrome: update on the complement system and what is new.
    Hirt-Minkowski P; Dickenmann M; Schifferli JA
    Nephron Clin Pract; 2010; 114(4):c219-35. PubMed ID: 20090363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The development of atypical haemolytic-uraemic syndrome is influenced by susceptibility factors in factor H and membrane cofactor protein: evidence from two independent cohorts.
    Fremeaux-Bacchi V; Kemp EJ; Goodship JA; Dragon-Durey MA; Strain L; Loirat C; Deng HW; Goodship TH
    J Med Genet; 2005 Nov; 42(11):852-6. PubMed ID: 15784724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. De novo gene conversion in the RCA gene cluster (1q32) causes mutations in complement factor H associated with atypical hemolytic uremic syndrome.
    Heinen S; Sanchez-Corral P; Jackson MS; Strain L; Goodship JA; Kemp EJ; Skerka C; Jokiranta TS; Meyers K; Wagner E; Robitaille P; Esparza-Gordillo J; Rodriguez de Cordoba S; Zipfel PF; Goodship TH
    Hum Mutat; 2006 Mar; 27(3):292-3. PubMed ID: 16470555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in understanding the aetiology of atypical Haemolytic Uraemic Syndrome.
    Sánchez-Corral P; Melgosa M
    Br J Haematol; 2010 Sep; 150(5):529-42. PubMed ID: 20629662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.